• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-10-02

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2 signaling and angiogenesis, particularly biochemical, cellular, and tumor angiogenesis workflows. Its water insolubility and defined kinase selectivity make it unsuitable for water-based formulations, broad-spectrum kinase screening, or direct clinical efficacy conclusions.

• Sulfo-NHS-Biotin for SEC-seq Workflows

  2026-10-01

  Sulfo-NHS-Biotin adds a surface-phenotype layer to secretion-focused single-cell workflows without replacing the secretion or transcriptome readouts. This guide explains how to combine amine-reactive labeling with nanovial-based SEC-seq, affinity capture, and immunoprecipitation while protecting cell viability and assay specificity.

• Adamtsl3, MMP9, and Perineuronal Net Plasticity

  2026-10-01

  The 2026 Molecular Psychiatry study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons. Its genetic and pharmacological experiments connect Adamtsl3 loss with elevated MMP9 activity, oxidative stress, impaired Otx2 uptake, and the return of juvenile-like cortical plasticity in adult mice.

• BV6 and the Cell-Death Decision: From IAPs to Translation

  2026-09-30

  BV6 is a Smac mimetic and selective IAP antagonist that helps translational researchers interrogate apoptosis, therapy resistance, and cell-death pathway context. This article connects BV6 evidence in cancer and endometriosis models with the RIPK3–MLKL insights reported in Orientia tsutsugamushi infection biology, while distinguishing established findings from forward-looking experimental opportunities.

• CD38 CAR Binders: Structure-Guided Affinity Tuning

  2026-09-30

  Cheng et al. define how the CD38 CAR binders RP02 and 028 engage different antigen surfaces and differently regulate CD38 enzymatic activity. Structural mapping, alanine scanning, and CAR-T testing show that attenuating 028 affinity can reduce fratricide while preserving antitumor cytotoxicity, providing a rational framework for CD38-directed receptor design.

• nor-Binaltorphimine dihydrochloride Workflow

  2026-09-29

  Build cleaner κ-opioid receptor experiments with a selective antagonist workflow tailored to mechanical hypersensitivity, receptor-subtype dissection, and circuit validation. This guide connects the 2024 mouse circuit study with practical stock preparation, assay controls, and troubleshooting for opioid receptor signaling research.

• A40926 Production Engineering in Nonomuraea

  2026-09-29

  Yushchuk et al. developed promoter-probe tools for the genetically recalcitrant genus Nonomuraea and used them to identify regulatory strategies for improving A40926 biosynthesis. Overexpression of pathway-specific positive regulators increased production in Nonomuraea gerenzanensis, providing a knowledge-based framework for glycopeptide antibiotic strain improvement.

• RNase Control: The Hidden Variable in mRNA Vaccines

  2026-09-28

  A translational perspective on how RNase surveillance can strengthen simple mRNA–liposome workflows, informed by a 2026 murine cancer-vaccine study and enabled by RNase Alert-Plus.

• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-09-28

  BFH772 is a small-molecule VEGFR2 inhibitor for experiments investigating VEGFR2-dependent signaling and angiogenesis, including tumor angiogenesis models. Its reported potency and organic-solvent solubility support controlled assay use, but its water insolubility makes it unsuitable for workflows that require direct aqueous formulation; the enzyme IC50 should not be treated as a universal cellular dose.

• Protease Inhibitor Cocktail for OXPHOS Studies

  2026-09-27

  Protect protein-level readouts in OXPHOS cancer experiments with an EDTA-free inhibitor workflow designed for cold, rapid extraction. This guide connects the LRPPRC–dasatinib finding to practical Western blot, co-immunoprecipitation, and kinase-assay preparation—without confusing protein preservation with RNA or phosphatase control.

• GSK621: AMPK Signaling for Translational Research

  2026-09-26

  AMPK activation can connect cellular energy sensing to lipid metabolism, autophagy, and cancer-cell fate. This article examines how GSK621 can support pathway interrogation, what recent macrophage research adds to the translational picture, and how to design experiments that distinguish a useful pharmacological signal from a disease-relevant mechanism.

• From Host Signaling to Surface Phenotypes

  2026-09-25

  Host-directed infection research depends on linking pathway perturbations to measurable cellular outcomes. This article explores how Sulfo-NHS-Biotin can help translational teams investigate accessible cell-surface protein changes alongside, but distinct from, intracellular signaling studies.

• Graphene-Mediated FIR Triggers Melanoma Cell Death

  2026-09-25

  Zhao and colleagues report that graphene-mediated far-infrared radiation suppresses melanoma cell growth, promotes apoptosis and G0/G1 arrest, and inhibits tumor growth in a mouse model. Inhibitor-rescue experiments implicate caspase-9 and caspase-3 in the cell-death response, while transcriptomic and hypoxia-related findings point to additional effects that need further mechanistic testing.

• BFH772 (VEGFR2 inhibitor): Research Workflow

  2026-09-24

  BFH772 is a small-molecule VEGFR2 inhibitor for researchers testing VEGFR2-associated signaling and angiogenesis in controlled cell or animal-model workflows. Its organic-solvent solubility and limited dossier information on dosing make it unsuitable for water-only formulations or for studies that require a validated in vivo regimen without prior optimization.

• Tetrandrine Workflows for Calcium Signaling Research

  2026-09-24

  Use Tetrandrine as a DMSO-soluble natural-product probe to connect calcium-channel perturbation with electrophysiology, calcium imaging, and downstream cell responses. A staged dosing and control strategy helps distinguish channel-related effects from precipitation, vehicle effects, or loss of viability.

7986 records 1/533 page Next 12345 下5页 Last page